Medical News

RSS

Avita commences enrollment in ReCell study for hypertrophic dyspigmented scars

Avita Medical Ltd.,the regenerative medicine company, today announced that it has commenced enrolment in the US FDA-approved feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars.

16 May 2012

Palpitations, hypertension strongest risk factors for AF

A large cohort study has found that the strongest risk factors for atrial fibrillation in both men and women were a history of palpitations and hypertension. While hypertension is a well known risk factor for AF, the investigators note that "the impact of self-reported palpitations on later occurrence of AF has not been documented earlier".

16 May 2012

Nile reports net operating loss of $0.8M for first quarter 2012

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its first quarter financial results for 2012.

16 May 2012

Modest alcohol consumption linked with less evidence of steatohepatitis

NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population. NAFLD is often associated with obesity and other parameters of the so-called "metabolic syndrome," which is a major risk factor for the development of cardiovascular disease.

16 May 2012

Intriguing links between Snf2l gene and brain developmental disorders

Scientists at the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) have discovered that mice that lack a gene called Snf2l have brains that are 35 per cent larger than normal.

16 May 2012

Combination of vaccine and letrozole effectively improves survival from breast cancer

A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found.

16 May 2012

VA releases task force draft plan to address women Veterans' issues

The Department of Veterans Affairs is releasing for public comment a draft of its strategic report to address key issues facing women Veterans. The plan outlines steps for improvements to care and services for women Veterans that are sustainable, accountable and a part of the department's culture and operations.

16 May 2012

EvergreenHealth announces recipients of 2012 Nursing Excellence awards

In celebration of National Nurses Week, EvergreenHealth recently recognized the exceptional care its nursing teams across the organization provide to enrich the health and well-being of each life they touch with the organization's annual Nursing Excellence awards. The organization awarded a group of exemplary caregivers during its nursing awards ceremony on May 8, 2012.

16 May 2012

Covidien acquires superDimension

Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.

16 May 2012

Partnership for Patients initiative participants launch sprint program to prevent pressure ulcers

Hospitals participating in the Partnership for Patients initiative have launched a program to prevent pressure ulcers.

16 May 2012

HyperBranch’s Adherus AutoSpray Dural Sealant receives CE Marking

HyperBranch Medical Technology, Inc. announced today that it has received CE Marking for Adherus AutoSpray Dural Sealant.

16 May 2012

Medical Marijuana reports net income of $1.21M for first quarter 2012

Medical Marijuana, Inc., one of the medical marijuana (MMJ) industry's premier cannabis and hemp industry innovators, today announced its first quarter earnings. The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012.

16 May 2012

Two new mouse models can help treat food allergies

Food allergies pose a serious and growing problem in the West. Many foods can lead to allergic reactions and this situation is further complicated by so-called cross-reactions, whereby an allergy to one particular food can trigger allergic reactions to another food. There are no treatments available for food allergies, but the establishment of two mouse models can be used to develop and test new forms of treatment, for example vaccines.

16 May 2012

Vejthani Hospital offers most effective procedure in gender selection

Vejthani Hospital Bangkok recommends a gender selection procedure for a couple who desire to choose a child's gender at Vejthani ART Center.

16 May 2012

Thermo Fisher signs asset purchase agreement with Nephromics for PlGF assay

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.

From Thermo Fisher Scientific Inc. 16 May 2012

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Pfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.

16 May 2012

MedClean 2011 total revenue increases 91% to $1,717,721

MedClean Technologies, Inc. today announced financial results for the 12-month period ended December 31, 2011.

16 May 2012

First study to compare complication rates after RAPN and LPN

Robot-assisted surgery has replaced another minimally invasive operation as the main procedure to treat kidney cancer while sparing part of the diseased organ, and with comparable results, according to a new research study by Henry Ford Hospital urologists.

16 May 2012

Two specific gene variants speed progression of Parkinson's disease

UCLA researchers may have found a key to determining which Parkinson's disease patients will experience a more rapid decline in motor function, sparking hopes for the development of new therapies and helping identify those who could benefit most from early intervention.

16 May 2012

Positive results from Boston Scientific's Lotus Aortic Valve System trial

Boston Scientific Corporation announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe aortic valve disease.

16 May 2012